DTLGX
Price
$52.38
Change
+$0.21 (+0.40%)
Updated
Dec 4 closing price
Net Assets
288.13M
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

DTLGX vs VIGRX

Header iconDTLGX vs VIGRX Comparison
Open Charts DTLGX vs VIGRXBanner chart's image
Wilshire Large Company Growth Invmt
Price$52.38
Change+$0.21 (+0.40%)
VolumeN/A
Net Assets288.13M
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
DTLGX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
DTLGX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTLGX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. DTLGX (288M). VIGRX pays higher dividends than DTLGX: VIGRX (0.30) vs DTLGX (0.00). DTLGX was incepted earlier than VIGRX: DTLGX (33 years) vs VIGRX (33 years). DTLGX (1.32) is less costly to investors than VIGRX (0.17). DTLGX is a more actively managed with annual turnover of: 66.00 vs. VIGRX (11.00). DTLGX has a lower initial minimum investment than VIGRX: DTLGX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. DTLGX (6.73). VIGRX return over 5 years is better than : 99.11 vs. DTLGX (-1.31).
DTLGXVIGRXDTLGX / VIGRX
Total Expense Ratio1.300.17765%
Annual Report Gross Expense Ratio1.320.17776%
Fund Existence33 years33 years-
Gain YTD22.60919.764114%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets288M357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year6.7318.4936%
Returns for 3 years60.22110.8254%
Returns for 5 years-1.3199.11-1%
Returns for 10 years24.19349.137%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT